Atezolizumab intravenous infusion used to treat certain lung, liver and bladder cancers
Contains atezolizumab 1200 mg/20 ml, an immunotherapy biologic (PD-L1 inhibitor) that helps the immune system recognize and attack cancer cells, used for certain lung, liver, bladder and breast cancers.
Attributes
Product Content
How to Use:
• Administered only by a doctor or nurse by intravenous infusion in a hospital setting.
• Dose and schedule are decided by your oncologist.
• Report any new symptoms (cough, diarrhea, rash) to your doctor promptly, as they may signal immune-related side effects.
• Prescription medicine; take exactly as prescribed and consult your doctor before use.
The link to Tecentriq 1200mg/20ml (IV Infusion) 1 Vial (Refrigerated) has been copied